688658 悦康药业
2025/03 - 三个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额81,042438,241785,492(121,169)515,239
投资活动产生之现金流量净额(1,769)(545,759)(502,047)(556,545)(200,836)
筹资活动产生之现金流量净额63,731(28,460)(432,192)(101,604)(408,276)
汇率变动对现金及现金等价物的影响442643,9366,203(913)
现金及现金等价物净增加/(减少)143,048(135,714)(144,812)(773,115)(94,786)
期初现金及现金等价物余额1,237,8121,373,5331,518,3452,291,4602,386,246
期末现金及现金等价物余额1,380,8591,237,8191,373,5331,518,3452,291,460